Novo Nordisk

Novo nordisk's data management department was established in Bangalore, India in the month of September 2007 and has significantly grown from 10 members to a strong team of over 140 Clinical Data Management professionals. It has witnessed significant transformations right from providing DM services to IO region reporting to IOCDC to becoming an integral part of Global development from Aug 2010. It is a young, enthusiastic and dynamic team with varied skillsets and professionals from diverse backgrounds such as pharmacy, life-sciences, physiotherapy, computer / information sciences and business administration.

Post :  Clinical Data Manager

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post : Jr Professional

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Regulatory Affairs Analyst

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Regulatory Publishing - RA Associate

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen.

Post : Marketing Executive-India Affiliate

[adsense:336x280:8701650588]

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Change Manager

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B).

Post: Global Project Manager

Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within Haemophilia care, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 33,300 employees in 75 countries, and markets its products in more than 190 countries Novo Nordisk’s B shares are listed on NASDAQ OMX Copenhagen (Novo-B). Novo Nordisk is one of the world’s most successful global pharmaceutical companies having a reputed history for bringing innovative therapeutic products to patients worldwide and having a great long-term growth potential.

Post : Pharma Patent Attorney

The India operations are housed at Bangalore, India. Although Novo Nordisk India Pvt Ltd was set up on 1st April 1994 in Bangalore, Novo Nordisk Insulins have been present in India from 1935 when insulin was imported to India. That makes it more than 75 years of uninterrupted supply of Novo Nordisk Insulin in India.  India is one of the fastest growing economies in the world with a population of around 1.2 billion people. India also has one of the largest number of people afflicted with diabetes - 61.3 million (IDF 5th Diabetes Atlas) . Novo Nordisk India is thus constantly challenged in its efforts in diabetes care to deliver products and services to an ever increasing number of people affected by diabetes

Post : Business Development Manager